Reports
Sale
Global Biochip Market Share, Trends, Analysis, Forecast: By Technology: Microarray, Microfluidics; By Type: DNA Chips, Lab-On-a-Chips, Protein Chips, Others; By Application: Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Others; By End User; By Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Global Biochip Market Outlook
The global biochip market size was valued at USD 6.7 billion in 2023, driven by the rising prevalence of chronic diseases, and increased preference for personalized medicine across the globe. The market is expected to grow at a CAGR of 14.36% during the forecast period of 2024-2032, with the values likely to rise from USD 14.2 billion in 2024 to USD 41.4 billion by 2032.
Global Biochip Market Overview
Biochips, also known as miniaturized laboratories, are portable medical devices that allow many biochemical reactions to occur simultaneously. They are integrated with biosensors, which can screen a diverse spectrum of biological materials including DNA, antibodies, proteins, and enzymes. Technological advancements in the biomedical sector have led to a continuous reduction in the size of biochips. The small size of biochips, in return, has resulted in high output and lower manufacturing costs.
Biochip market demand has experienced a surge due to the rising prevalence of chronic diseases. Chronic diseases are responsible for 74% of global mortality each year, affecting around 41 million people, according to the World Health Organization (WHO). Cardiovascular diseases cause 17.9 million deaths whereas cancers account for 4.1 million deaths. To address the alarming rise of chronic diseases, appropriate therapeutic and diagnostic solutions are needed. Biochips can facilitate quick and accurate diagnosis of diseases like cancer, enabling prompt treatment of patients with chronic conditions.
In addition, the increased adoption and demand for personalized medicine is expected to accelerate the market growth. Other market drivers include technological advancements pushing the development of innovative products, along with a significant increase in strategic partnerships among prominent biotechnology companies.
Novel Innovations Driving the Biochip Market Growth
One significant trend in the biochip market is the development of innovative products to meet rising demand in the healthcare sector. In November 2023 , a novel biochip imitating the retina of the eye was developed by an international team of scientists led by Francesca Santoro, a researcher at RWTH Aachen University, Germany. Based on light-sensitive molecules and conductive polymers, the new biochip can improve the integration of retinal implants in the human body in the coming years. Since the retina-like biochip is made of non-toxic organic materials, it will be more suitable for biological systems as compared to silicon-containing semiconductor components.
Therapeutic Developments in Biochip Technology
Several companies are leveraging interdisciplinary research to discover potential therapeutic solutions, poised to elevate the biochip market share in the forecast period. In November 2023 , a startup company Axoniverse started by Arizona State University students, developed a biochip called Axomini which integrates both biology and biocomputational technology. The biochip attempts to utilize the neuron’s natural communication mechanism to process information. The company intends to create biochips that mimic complex biological patterns, similar to the ones witnessed in Alzheimer’s disease to aid both therapeutic and technological advancements.
Global Biochip Market Segmentation
Market Breakup by Technology
- Microarray
- Microfluidics
Market Breakup by Type
- DNA Chips
- Lab-On-a-Chips
- Protein Chips
- Others
Market Breakup by Application
- Drug Discovery and Development
- Disease Diagnostics
- Genomics
- Proteomics
- Others
Market Breakup by End User
- Hospitals and Diagnostic Centers
- Academics and Research Institutes
- Biotechnology and Pharmaceutical Companies
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Biochip Market Regional Analysis
North America holds the largest share of the biochip market owing to the technological advancements in the healthcare infrastructure in the region. With its rising applications across wide range of sectors such as drug discovery and development, the market demand for biochips is growing notably. Diagnostic screening is another significant area of biochips application. In August 2023 , Opteev Technologies, a health safety technology in the United States announced that it would file a patent for its latest multiplex biochip that can test multiple pathogens including SARS-CoV-2. The polymer-based biochip is integrated with artificial intelligence to ensure quick and accurate detection of a virus or bacteria within a minute.
Europe also holds a significant biochip market share which can be attributed to the presence of major research institutes and leading biotech companies in the region. In Asia Pacific, the large population size has fuelled the demand for innovative biochips. With the growing impetus of the government to improve healthcare facilities, developing economies in the region are expected to offer lucrative growth opportunities for the key market players in the coming years.
Global Biochip Market: Competitor Landscape
In July 2023 , a Lebanese biotech company DLOC Biosystems (DLOC) announced a strategic partnership with a product design and technology innovation consultancy, 42 Technology (42T). The company plans to leverage the product development partner to develop its fully automated 3D human-on-chip technology. 42T will collaborate with the in-house engineering team of DLOC to optimize the design of DLOC biochips and work on the design prototype of the human-on-chip system. Such events of collaboration facilitate the sharing of resources and expertise, thus aiding in the expansion of biochip market size in the forecast period.
The key features of the market report include patent analysis, grants analysis, funding analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories Inc.
- Agilent Technologies, Inc.
- PerkinElmer Inc.
- Fluidigm Corporation
- Illumina, Inc.
- GE Healthcare Inc.
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche AG
- BioMérieux SA
- HORIBA, Ltd.
- QIAGEN N.V.
- Randox Laboratories Ltd.
- OriGene Technologies, Inc.
- Cepheid (Danaher Corporation)
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biochip Market Overview
3.1 Global Biochip Market Historical Value (2017-2023)
3.2 Global Biochip Market Forecast Value (2024-2032)
4 Global Biochip Market Landscape*
4.1 Global Biochip Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biochip Market: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Application
5 Global Biochip Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biochip Market Segmentation
6.1 Global Biochip Market (2017-2032) by Technology
6.1.1 Market Overview
6.1.2 Microarray
6.1.3 Microfluidics
6.2 Global Biochip Market (2017-2032) by Type
6.2.1 Market Overview
6.2.2 DNA Chips
6.2.3 Lab-On-a-Chips
6.2.4 Protein Chips
6.2.5 Others
6.3 Global Biochip Market (2017-2032) by Application
6.3.1 Market Overview
6.3.2 Drug Discovery and Development
6.3.3 Disease Diagnostics
6.3.4 Genomics
6.3.5 Proteomics
6.3.6 Others
6.4 Global Biochip Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals and Diagnostic Centers
6.4.3 Academics and Research Institutes
6.4.4 Biotechnology and Pharmaceutical Companies
6.4.5 Others
6.5 Global Biochip Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Biochip Market (2017-2032)
7.1 North America Biochip Market (2017-2032) by Technology
7.1.1 Market Overview
7.1.2 Microarray
7.1.3 Microfluidics
7.1.4 Others
7.2 North America Biochip Market (2017-2032) by Type
7.2.1 Market Overview
7.2.2 DNA Chips
7.2.3 Lab-On-a-Chips
7.2.4 Protein Chips
7.2.5 Others
7.3 North America Biochip Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Biochip Market (2017-2032)
8.1 Europe Biochip Market (2017-2032) by Technology
8.1.1 Market Overview
8.1.2 Microarray
8.1.3 Microfluidics
8.1.4 Others
8.2 Europe Biochip Market (2017-2032) by Type
8.2.1 Market Overview
8.2.2 DNA Chips
8.2.3 Lab-On-a-Chips
8.2.4 Protein Chips
8.2.5 Others
8.3 Europe Biochip Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Biochip Market (2017-2032)
9.1 Asia Pacific Biochip Market (2017-2032) by Technology
9.1.1 Market Overview
9.1.2 Microarray
9.1.3 Microfluidics
9.1.4 Others
9.2 Asia Pacific Biochip Market (2017-2032) by Type
9.2.1 Market Overview
9.2.2 DNA Chips
9.2.3 Lab-On-a-Chips
9.2.4 Protein Chips
9.2.5 Others
9.3 Asia Pacific Biochip Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 ASEAN
9.3.6 Others
10 Latin America Biochip Market (2017-2032)
10.1 Latin America Biochip Market (2017-2032) by Technology
10.1.1 Market Overview
10.1.2 Microarray
10.1.3 Microfluidics
10.1.4 Others
10.2 Latin America Biochip Market (2017-2032) by Type
10.2.1 Market Overview
10.2.2 DNA Chips
10.2.3 Lab-On-a-Chips
10.2.4 Protein Chips
10.2.5 Others
10.3 Latin America Biochip Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Biochip Market (2017-2032)
11.1 Middle East and Africa Biochip Market (2017-2032) by Technology
11.1.1 Market Overview
11.1.2 Microarray
11.1.3 Microfluidics
11.1.4 Others
11.2 Middle East and Africa Biochip Market (2017-2032) by Type
11.2.1 Market Overview
11.2.2 DNA Chips
11.2.3 Lab-On-a-Chips
11.2.4 Protein Chips
11.2.5 Others
11.3 Middle East and Africa Biochip Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Abbott Laboratories Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Agilent Technologies, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 PerkinElmer Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Fluidigm Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Illumina, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 GE Healthcare Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Bio-Rad Laboratories Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Thermo Fisher Scientific, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 F. Hoffmann-La Roche AG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 BioMérieux SA
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 HORIBA, Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 QIAGEN N.V.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Randox Laboratories Ltd.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 OriGene Technologies, Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Cepheid (Danaher Corporation)
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
List not exhaustive
18 Global Biochip Market (2017-2032) - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 6.7 billion in 2023 driven by the rising prevalence of chronic diseases across the globe.
The market is anticipated to grow at a CAGR of 14.36% during the forecast period of 2024-2032, likely to reach a market value of USD 41.4 billion by 2032.
The increased preference for personalized medicine and the growing technological advancements in the biomedical industry are fuelling the demand for technologically advanced biochip devices.
One of the significant trends in the market is the development of innovative biochips to meet the rising demand in the healthcare sector. In November 2023, a novel biochip imitating the retina of the eye was developed by an international team of scientists. Based on light-sensitive molecules and conductive polymers, the new biochip could be more suitable for biological systems as compared to silicon-containing semiconductor components.
The various technologies in the market are microarray and microfluidics.
Based on the type, the market is segmented into DNA chips, lab-on-a-chips, and protein chips, among others.
Major end users of biochips include hospitals and diagnostic centers, academics and research institutes, and biotechnology and pharmaceutical companies, among others.
Biochips are used in drug discovery and development, disease diagnostics, genomics, and proteomics, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Abbott Laboratories Inc., Agilent Technologies, Inc., PerkinElmer Inc., Fluidigm Corporation, Illumina, Inc., GE Healthcare Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, BioMérieux SA, HORIBA, Ltd., QIAGEN N.V., Randox Laboratories Ltd., OriGene Technologies, Inc., and Cepheid (Danaher Corporation).
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER